Study shows low vaccination rates among expectant mothers in Norway against COVID-19, influenza
Medical Xpress
February 19, 2026
AI-Generated Deep Dive Summary
A new study reveals alarmingly low vaccination rates among expectant mothers in Norway during the 2023/24 influenza season. Only 29.9% of pregnant women were vaccinated against influenza, while just 12.1% received the COVID-19 vaccine during pregnancy. These figures fall significantly below recommended targets, raising concerns about public health vulnerabilities.
The study, conducted by the Norwegian Institute of Public Health and published in Eurosurveillance, analyzed data from over 50,000 pregnant women. It highlights that vaccination rates for both influenza and COVID-19 remain stubbornly low despite clear evidence of their benefits. Vaccination during pregnancy is crucial as it not only protects the mother but also confers immunity to the unborn child.
The findings underscore a critical gap in maternal health protection. Both influenza and COVID-19 pose significant risks to pregnant women and their fetuses, including complications like preterm birth and severe illness requiring hospitalization. Low vaccination rates suggest a need for improved education and access to vaccines among healthcare providers and expectant mothers.
This issue is particularly concerning given Norway's robust healthcare system and its historical high vaccination rates in other populations. The study points to potential barriers such as misinformation, lack of awareness, or limited access to care. Addressing these factors could help boost vaccination rates and safeguard both maternal and neonatal health.
The implications extend beyond Norway, offering valuable insights for global health initiatives aimed at improving vaccination coverage among expectant
Verticals
healthmedical
Originally published on Medical Xpress on 2/19/2026